Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Decapeptyl CR - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Decapeptyl CR

Approved

STANDARD

Decapeptyl CR

Ferring GmbH🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: b9f5490459caa9d3
Company: Ferring GmbH
Type: Standard

Approval Details

Approval Id: b9f5490459caa9d3
Drug Approval Philippines Name: Decapeptyl CR
Product Name: Decapeptyl CR
Registration Number: DR-XY26657
Brand Name: Decapeptyl CR
Generic Name: Triptorelin Acetate
Dosage Form: Powder For Suspension For Injection
Dosage Strength: 4.12 mg (equivalent to 3.75 mg Triptorelin)
Manufacturer: Ferring GmbH
Importer: Metro Drug, Inc.
Distributor: Metro Drug, Inc.
Company Detail Path: /organization/ferring-gmbh
Issuance Date: 26 April 2025
Expiry Date: 08 April 2031
Pharmacologic Category: Gonadotropin-Releasing Hormone Analogue
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

b9f5490459caa9d3

Type

Standard

Back to Philippines FDA Approvals